Aurobindo Pharma Ltd.’s first-quarter profit rose, in-line with analysts’ estimates.The Hyderabad-based bulk and generic drug maker’s net profit rose 10% year-on-year to Rs 571 crore in the quarter ended June, according to an exchange filing. That compares with the Rs 557-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, it rose 13%.
The Kinneret (Sea of Galilee) has ended March 2026 just above the bottom red line following heavy rainfall over...
Crude oil prices saw considerable volatility last week. Brent crude oil futures on the Intercontinental Exchange (ICE) ($105.30/barrel) was down 6.1...
The war in Iran is “incomparable” with any past oil shock in both its scale and its wide-ranging impact on...
Eternal shares on Friday rose 3% from the day's low of Rs 230.10 on the NSE to scale the day's...
A haunting whale song discovered on decades-old audio equipment could open up a new understanding of how the huge animals communicate, according...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
